Melinta Therapeutics (CEMP) Gross Profit Margin starting from the third quarter 2019 to third quarter 2018, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Melinta Therapeutics, Inc.  (CEMP)


Melinta Therapeutics's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CEMP Gross Profit Margin (Sep 30 2019)
Q3 		(Jun 30 2019)
Q2 		(Mar 31 2019)
Q1 		(Dec 31 2018)
Q4 		(Sep 30 2018)
Q3
Y / Y Revenue Change -53.43 %
Seq. Revenue Change -0.53 %
Revenue In Millions $15.87
Gross Profit Margin 48.25 %
Gross Profit Margin Total Ranking # 1985
Gross Profit In Millions $7.66
Y / Y Gross Profit Change -62.98 %
Seq. Gross Profit Change 4.66 %


Commenting Third Quarter 2019 Gross Profit Margin
Melinta Therapeutics, Inc. achieved Gross Profit of $8 millions compare to Gross Loss of $7.32 millions booked in the previous quarter. Despite the sequential Revenue deterioration in Q3 of -0.53 % Melinta Therapeutics, Inc. managed to reduce Cost of Sales and increase Gross Profit by 4.66 % to $8 millions. Gross Profit Margin grew to 48.25 %, above company average Gross Profit Margin.


Observing third quarter 2019 results within Major Pharmaceutical Preparations industry 126 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 1985, from total ranking in the previous quarter at 2102.
Learn about Gross Margin
CEMP's Gross Profit Margin third quarter 2019 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 127
Healthcare Sector # 332
Overall # 1931

Gross Profit Margin Statistics
High Average Low
74.67 % 43.11 % 8.59 %
(Dec 31 2018)   (Jun 30 2018)


CEMP Gross Income Trends • More of CEMP's Profitabilty Ratios • CEMP Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
CEMP's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
CEMP's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for CEMP's Competitors
Gross Profit Margin Profit Margin for Melinta Therapeutics's Suppliers
Gross Profit Margin Profit Margin for CEMP's Customers

You may also want to know
CEMP's Annual Growth Rates CEMP's Profitability Ratios CEMP's Asset Turnover Ratio CEMP's Dividend Growth
CEMP's Roe CEMP's Valuation Ratios CEMP's Financial Strength Ratios CEMP's Gross Profit Growth
CEMP's Roa CEMP's Inventory Turnover Ratio CEMP's Growth Rates CEMP's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2019, within Major Pharmaceutical Preparations Industry Gross Profit MarginSep 30 2019 MRQ Gross ProfitSep 30 2019 MRQ Revenue
Ayala Pharmaceuticals Inc   100.00 %$ 0.001  Millions$ 0.001  Millions
Lexicon Pharmaceuticals Inc   99.80 %$ 293.871  Millions$ 294.448  Millions
Nabriva Therapeutics Plc  99.78 %$ 6.905  Millions$ 6.920  Millions
Ironwood Pharmaceuticals inc   99.61 %$ 130.661  Millions$ 131.167  Millions
Ionis Pharmaceuticals Inc   99.42 %$ 166.925  Millions$ 167.892  Millions
Intercept Pharmaceuticals inc   99.21 %$ 61.463  Millions$ 61.950  Millions
Omeros Corporation  99.07 %$ 29.578  Millions$ 29.856  Millions
Rigel Pharmaceuticals Inc  98.51 %$ 20.547  Millions$ 20.857  Millions
Agios Pharmaceuticals Inc   98.49 %$ 25.631  Millions$ 26.024  Millions
Corcept Therapeutics Inc  98.22 %$ 80.054  Millions$ 81.505  Millions
Vaccinex Inc   98.02 %$ 0.396  Millions$ 0.404  Millions
Skinvisible Inc   97.79 %$ 0.011  Millions$ 0.011  Millions
Acadia Pharmaceuticals Inc   97.45 %$ 92.170  Millions$ 94.586  Millions
Emmaus Life Sciences Inc   97.07 %$ 5.906  Millions$ 6.084  Millions
Travere Therapeutics Inc   96.59 %$ 42.860  Millions$ 44.373  Millions
Celgene Corp  96.31 %$ 4,353.000  Millions$ 4,520.000  Millions
Sage Therapeutics Inc   96.16 %$ 3.433  Millions$ 3.570  Millions
Assertio Holdings inc   95.93 %$ 52.904  Millions$ 55.147  Millions
Ptc Therapeutics inc   95.79 %$ 68.410  Millions$ 71.416  Millions
Verastem Inc   95.66 %$ 8.640  Millions$ 9.032  Millions
Supernus Pharmaceuticals inc   95.28 %$ 97.321  Millions$ 102.140  Millions
Regeneron Pharmaceuticals Inc   94.34 %$ 1,932.500  Millions$ 2,048.400  Millions
Therapeuticsmd Inc   93.91 %$ 22.275  Millions$ 23.720  Millions
Adamas Pharmaceuticals Inc  93.33 %$ 13.004  Millions$ 13.933  Millions
Durect Corp  93.21 %$ 10.032  Millions$ 10.763  Millions
Jazz Pharmaceuticals Plc  93.16 %$ 500.921  Millions$ 537.702  Millions
Portola Pharmaceuticals inc   92.71 %$ 34.115  Millions$ 36.799  Millions
Alnylam Pharmaceuticals Inc   92.56 %$ 64.848  Millions$ 70.061  Millions
Pfenex Inc   92.50 %$ 14.105  Millions$ 15.248  Millions
Alexion Pharmaceuticals Inc   92.46 %$ 1,167.900  Millions$ 1,263.100  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.